NCT07256028 (IAA-EED) is a NA clinical trial of Indispensable amino acids supplemntation in Environmental Enteric Dysfunction, sponsored by Morocco's National Centre for Energy, Sciences and Nuclear Techniques.

Who is sponsoring NCT07256028?

NCT07256028 is sponsored by Morocco's National Centre for Energy, Sciences and Nuclear Techniques.

What drugs are being tested in NCT07256028?

Interventions in NCT07256028: Indispensable amino acids supplemntation, Without Indispensable amino acids supplementation.

What condition does NCT07256028 study?

NCT07256028 studies Environmental Enteric Dysfunction.

Is NCT07256028 still recruiting?

NCT07256028 is currently not yet recruiting. Last updated 1 December 2025.

Last reviewed 2025-12-01 · How we verify

NCT07256028: IAA-EED

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Indispensable Amino Acids Bioavailability in Children With Environmental Enteropathy Dysfunction (IAA-EED)

Not yet recruiting NA Last updated 1 December 2025

What this trial tests

NA trial testing Indispensable amino acids supplemntation in Environmental Enteric Dysfunction in 40 participants. Not yet recruiting.

Timeline

10 December 2025

Primary endpoint
31 March 2026

31 July 2026

Quick facts

Lead sponsor	Morocco's National Centre for Energy, Sciences and Nuclear Techniques
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	40
Start date	10 December 2025
Primary completion	31 March 2026
Estimated completion	31 July 2026
Sites	1 location across Morocco

Drugs / interventions tested

Indispensable amino acids supplemntation
Without Indispensable amino acids supplementation

Conditions studied

Environmental Enteric Dysfunction — all drugs for Environmental Enteric Dysfunction →

Sponsor

Morocco's National Centre for Energy, Sciences and Nuclear Techniques

Who can join

Adults 18 Months to 36 Months, any sex, with Environmental Enteric Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In Morocco, large efforts have been made to enhance nutritional status and health conditions of children. Accordingly, stunting was reduced and the prevalence of stunting have decreased from 28,6% in 1987 to 14,9% in 2011. Many factors, including improved nutrition, have influenced this decrease, and are reinforced to maintain this low prevalence of stunting. Of interest, quality diet, specifically with reference to its protein quality, has contributed to improve the nutritional status of the Moroccan population. However, infectious diseases are still important and in some areas many children are of high risk to develop EED that alter intestinal permeability and microbial translocation, and lead to systemic inflammation. During childhood, protein supply is of a great interest and indigestibility of these proteins and/or malabsorption of indispensable amino acids will affect children growth and many physiological and cognitive functions. This project was planned to assess indispensable amino acids during EED and to to assess the impact of some interventions (amino acids supplementation / medical treatment) on the nutritional status of children. This study will be carried out according to a trilogy of close collaboration between CNESTEN, Pr Claire Gaudichon from AgroParisTech (France) who will provide technical assistance and scientific accompaniment during the progress of the project, she will also participate in the data analysis, exploitation and valorization of results and the department of Pediatric Hepatology Gastroenterology and Nutrition-P III at the Children's Hospital in Rabat.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of indispensable amino acid supplementation on gut function in children at high risk of environmental enteropathy: protocol for an international coordinated group of randomised controlled trials.
Lee GO, Owino V, Baquiran AFP, Pasanna RM, et al · · 2026 · PMID 42031499 · DOI 10.1136/bmjopen-2025-105456

Verify or expand the search:

Other recruiting trials for Environmental Enteric Dysfunction

Currently open trials in the same condition.

NCT07195006 — Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories · recruiting
NCT05501470 — Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07256028 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Morocco's National Centre for Energy, Sciences and Nuclear Techniques
Last refreshed: 1 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07256028.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing